AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy-Reference-Cited by-同舟云学术

AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy

Published:2012-08 Issue:2 Volume:53 Page:217-222
ISSN:0022-2828
Container-title:Journal of Molecular and Cellular Cardiology
language:en
Short-container-title:Journal of Molecular and Cellular Cardiology

Author:

Bostick Brian,Shin Jin-Hong,Yue Yongping,Wasala Nalinda B.,Lai Yi,Duan Dongsheng

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Molecular Biology

Reference27 articles.

1. Duchenne cardiomyopathy gene therapy;Shin,2010

2. Challenges opportunities in dystrophin-deficient cardiomyopathy gene therapy;Duan;Hum Mol Genet,2006

3. Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma;Chamberlain;FASEB J,2007

4. Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice;Li;Hum Mol Genet,2009

5. Gender influences cardiac function in the mdx model of Duchenne cardiomyopathy;Bostick;Muscle Nerve,2010

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic delivery of full-length dystrophin in Duchenne muscular dystrophy mice;Nature Communications;2024-07-21

2. Split intein-mediated protein trans-splicing to express large dystrophins;Nature;2024-07-17

3. Inhibition of miR-25 ameliorates cardiac and skeletal muscle dysfunction in aged mdx/utrn haploinsufficient (+/−) mice;Molecular Therapy - Nucleic Acids;2024-06

4. Potential limitations of microdystrophin gene therapy for Duchenne muscular dystrophy;JCI Insight;2024-05-07

5. Systemic Delivery of Full-Length Dystrophin in DMD Mice;2024-05-03